Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
57,127,897
-
Total 13F shares
-
58,541,619
-
Share change
-
+1,963,214
-
Total reported value
-
$523,363,001
-
Put/Call ratio
-
8.8%
-
Price per share
-
$8.94
-
Number of holders
-
108
-
Value change
-
+$15,175,340
-
Number of buys
-
57
-
Number of sells
-
42
Institutional Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q4 2024
As of 31 Dec 2024,
Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) was held by
108 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
58,541,619 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Vestal Point Capital, LP, BlackRock, Inc., Fairmount Funds Management LLC, FCPM III SERVICES B.V., TCG Crossover Management, LLC, VANGUARD GROUP INC, and VR Adviser, LLC.
This page lists
108
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.